FIELD: chemistry.
SUBSTANCE: described is a 15β-substituted oestradio derivative having selective oestrogenic activity. The preferred compound is 7α-ethyl-15β-methyl-19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17β-diol.
EFFECT: obtaining compounds which can be used in treating or preventing diseases or physiological conditions related to oestrogen receptors.
11 cl, 4 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| STEROID COMPOUNDS, METHOD FOR SELECTIVE MODIFICATION, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2255090C2 |
| COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
| 15,15-DIALKYLSTEROID COMPOUNDS AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2147306C1 |
| PROGESTERONE RECEPTOR MODULATORS | 2005 |
|
RU2381232C2 |
| NONAROMATIC ESTROGENIC STEROID, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2245886C2 |
| BRIDGE-CONTAINING ESTRATRIENES | 1990 |
|
RU2087479C1 |
| METHOD OF SYNTHESIS OF SULFATIZED ESTROGEN MIXTURE | 1998 |
|
RU2184741C2 |
| 18-METHYL-19-NORANDROST-4-ENE-17,17-SPIROETHER (18-METHYL-19-NOR-20-SPIROX-4-EN-3-ON) AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUND | 2007 |
|
RU2440365C2 |
| SULFAMATE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159774C2 |
| DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1995 |
|
RU2152952C2 |
